GoHearing Ultra vs Otofonix Groove

The GoHearing Ultra is a budget-priced behind-the-ear OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable price tier of the OTC market, though its overall sound performance ranks #58 of 65 devices in its category. In our testing, the Ultra shows a distinctive performance profile with significant strengths and weaknesses. Feedback handling is excellent at 5.0/5, scoring 0.46 points above the category average—users can expect stable operation without whistling during typical wear. Music streaming quality is also a genuine strength at 3.6/5, performing 1.68 points above average, making it notably better for phone audio than most OTC devices. However, speech clarity scores reveal meaningful limitations. Speech in quiet environments measured just 1.0/5, which is 1.79 points below the category average and low in absolute terms. Speech in noise similarly scored 1.0/5, falling 0.48 points below average. Own-voice comfort rated 1.9/5, also below the category norm. These results suggest the Ultra may struggle to deliver the speech audibility improvements that many users prioritize. The GoHearing Ultra may suit budget-conscious consumers who primarily want reliable streaming audio and feedback-free operation, and who have modest expectations for speech enhancement. However, several competitors in the same price range—including the Elehear Beyond and Apple AirPods Pro 2—deliver substantially stronger overall sound performance. Users prioritizing speech clarity should consider these alternatives despite similar pricing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.